CARI-STROKE
LIVE

Serial Number

79377793

Owner

Caristo Diagnostics Ltd

Attorney

GREGORY J. CHINLUND

Filing Date

Apr 12, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CARI-STROKE Trademark

Serial Number: 79377793 • Registration: 8131490

CARI-STROKE is a trademark filed by Caristo Diagnostics Ltd on April 12, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Caristo Diagnostics Ltd (6 trademarks)

New Barclay House, 234 Botley Road

Entity Type: 99

Trademark Details

Filing Date

April 12, 2023

Registration Date

February 10, 2026

Published for Opposition

December 23, 2025

Goods & Services

Downloadable computer software for use with medical patient monitoring, diagnostic and prognostic equipment for receiving, processing, transmitting, analysing, organising and displaying data; downloadable computer software relating to the medical field, namely, software for use in medical diagnosis; downloadable computer software for operating medical equipment, in particular, diagnostic and prognostic equipment; none of the aforementioned goods for use in the fields of workplace wellbeing, mental health, occupational psychology, coaching, training, performance monitoring and management, or organisational metrics in engagement and culture

Medical diagnostic and prognostic services; Medical diagnostic reporting services, namely, issuing of medical diagnostic reports; medical analysis for the diagnosis, prognosis and treatment of persons; medical analysis services relating to the analysis of patient health and medical data for the treatment of patients in the fields of cardiovascular, neurological, and metabolic disease; medical testing for diagnostic, prognostic or treatment purposes; consulting services relating to health care; human healthcare services for treating cardiovascular, neurological and metabolic disease; medical imaging services; none of the aforementioned services provided in respect of workplace wellbeing, mental health, occupational psychology, coaching, training, performance monitoring and management, or organisational metrics in engagement and culture

Preparation of business reports in the field of patient medical and healthcare data; none of the aforementioned services provided in respect of workplace wellbeing, mental health, occupational psychology, coaching, training, performance monitoring and management, or performance business metrics

Software development, programming and implementation in the field of medical imaging; medical and pharmacological research services; medical research; medical research services; scientific investigations for medical purposes; scientific research in the fields of cardiovascular disease and neurology for medical research purposes; software as a service (SaaS) services featuring computer software platforms using artificial intelligence for detection, diagnosis, prognosis and treatment of disease, in particular, cardiovascular, neurological and metabolic disease; software design and development; software engineering services; providing computer aided reagent sample diagnostic testing services for others for scientific research purposes; computer programming in the medical field; software as a service (SaaS) services featuring software for machine learning, collection, analysis and organisation of data in the field of deep learning and operation of deep neural networks; software as a service (SaaS) services featuring software for processing images related to CT image analysis; software as a service (SaaS) services featuring software for the analysis of data relating to the early detection, diagnosis, prognosis and treatment of disease, in particular, cardiovascular and metabolic disease; none of the aforementioned services provided in respect of workplace wellbeing, mental health, occupational psychology, coaching, training, performance monitoring and management, or organisational metrics in engagement and culture

Medical devices for diagnosis and prognosis of cardiovascular disease; medical devices for diagnosis and prognosis of metabolic disease; medical devices for evaluation of cardiovascular disease; medical devices for the evaluation of metabolic disease; medical apparatus for measuring inflammation in human tissue; medical diagnostic and prognostic apparatus for diagnostic and prognostic testing in the fields of cardiovascular disease and neurology; medical imaging apparatus; medical devices for analysing, storing, transmitting and organising medical data, in particular, data derived from medical scans and medical imaging

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 10, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2025 NONP
EXPARTE APPEAL TERMINATED
Nov 25, 2025 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 25, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 25, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 25, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 25, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 25, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2025 CRFA
ASSIGNED TO LIE
Oct 6, 2025 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 29, 2025 ERFR
EX PARTE APPEAL-INSTITUTED
Sep 29, 2025 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Sep 29, 2025 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Sep 29, 2025 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 28, 2025 GNFN
FINAL REFUSAL E-MAILED
Mar 28, 2025 GNFR
FINAL REFUSAL WRITTEN
Mar 28, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 24, 2025 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 15, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 26, 2025 OPNR
REFUSAL PROCESSED BY IB
Sep 30, 2024 RFNP
NON-FINAL ACTION WRITTEN
Aug 23, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2024 TROA
REFUSAL PROCESSED BY IB
Feb 14, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 25, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jan 25, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 10, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jan 9, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 9, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 5, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 31, 2023 REPR